mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.

Karl Berner, Naci Oz, Alaattin Kaya, Animesh Acharjee, Jon Berner

July 2024 Aging (Albany NY)

Synopsis of Social media discussions

The overall tone of the discussions is supportive and mildly engaged, exemplified by references to videos, podcasts, and summaries, indicating interest but not in-depth critique. Words like 'watch,' 'discuss,' and hashtags such as #aging and #neurology suggest a focus on potential implications and relevance for aging and brain health, contributing to a moderate overall impact perception.

A
Agreement
 Moderate agreement

Most discussions show support or curiosity toward the findings, with many referencing the potential significance of mTORC1 in health and disease.

I
Interest
 Moderate level of interest

Posts demonstrate moderate interest, often sharing links to videos or summaries, indicating curiosity but not deeply probing the research.

E
Engagement
 Moderate level of engagement

Many commenters engage by sharing their thoughts, watching videos about the research, or referencing related topics like aging and neuropsychiatric conditions, showing active but surface-level engagement.

I
Impact
 Moderate level of impact

The tone suggests that the research is considered relevant, with some posts hinting at its potential to influence aging studies and medical approaches, though widespread consensus on its transformative impact is limited.

Social Mentions

YouTube

2 Videos

Bluesky

2 Posts

Facebook

1 Posts

Twitter

28 Posts

News

1 Articles

Metrics

Video Views

894

Total Likes

46

Extended Reach

133,316

Social Features

34

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

mTORC1 Activation Links Human Size, Neuropsychiatric Diseases, and Treatment Response

mTORC1 Activation Links Human Size, Neuropsychiatric Diseases, and Treatment Response

This video discusses how mTORC1 activity correlates with physical traits like height and neuropsychiatric conditions, based on a study analyzing blood samples and clinical data to improve personalized treatment strategies.

Aging-US

October 23, 2024

672 views

mTORC1 in Monocytes Links Human Size and Neuropsychiatric Disorders

mTORC1 in Monocytes Links Human Size and Neuropsychiatric Disorders

This study investigates how mTORC1 activity in classical monocytes correlates with human size variation and neuropsychiatric conditions. Blood samples from 27 women revealed that mTORC1 activity predicts physical traits and treatment responses, aiding personalized medicine approaches.

Aging-US

August 6, 2024

222 views

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/4xgKhdLoLd #interview
    view full post

    July 22, 2025

    3

  • Aging-US
    @aging-us.bsky.social (Bluesky)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ www.youtube.com/watch?v=45L8... #interview #aging #oa
    view full post

    July 22, 2025

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/4xgKhdLoLd #interview
    view full post

    June 18, 2025

    2

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/4xgKhdLoLd #interview
    view full post

    May 15, 2025

    2

  • QuantumAI+Crispr3D=QuInCy=QAI&C3D=LA
    @1LEOOEL1 (Twitter)

    RT @AgingJrnl: Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in…
    view full post

    April 28, 2025

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/4xgKhdLoLd #interview
    view full post

    April 27, 2025

    3

    1

  • Rami EdgeLord
    @KhouryHopes (Twitter)

    RT @AgingJrnl: Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in…
    view full post

    March 27, 2025

    2

  • BillOckham
    @BillOccham0 (Twitter)

    RT @AgingJrnl: Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in…
    view full post

    March 27, 2025

    2

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/4xgKhdLoLd #interview
    view full post

    March 27, 2025

    2

    2

  • Aging-US
    @aging-us.bsky.social (Bluesky)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ www.youtube.com/watch?v=45L8... #aging #interview #series
    view full post

    March 27, 2025

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/wsoLVk9192 #interview https://t.co/w0V7jAyYLj
    view full post

    February 10, 2025

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/wsoLVk9192 #interview https://t.co/w9dz6n0PgC
    view full post

    January 28, 2025

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/wsoLVk9192 #interview https://t.co/t1VNEY7L58
    view full post

    December 16, 2024

    2

  • Walid Zahra
    @SciFi_Genetics (Twitter)

    RT @AgingJrnl: Watch an #agingshort #video about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correla…
    view full post

    December 7, 2024

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Watch an #agingshort #video about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease." @VCU_Biology @unibirmingham https://t.co/oowkEBZpAC #aging #neurology #oa #publishing https://t.co/niiNA1iQ2O
    view full post

    December 7, 2024

    3

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/wsoLVk9192 #interview https://t.co/qE2FKjom7E
    view full post

    November 24, 2024

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/wsoLVk9192 #interview https://t.co/q3u3lYcNOM
    view full post

    November 18, 2024

  • Aging-US
    @AgingJrnl (Twitter)

    Longevity & Aging Series (S2, E3): Dr. Jon Berner discusses the #research paper he co-authored, titled “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” Watch ⬇️ https://t.co/wsoLVk9192 #interview https://t.co/WCkfId32rC
    view full post

    October 23, 2024

  • Aging-US
    @AgingJrnl (Twitter)

    Listen to an #audio reading of the #pressrelease about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease." https://t.co/md3XFZV1ND #aging #soundcloud #podcast #press #openaccess
    view full post

    October 19, 2024

  • Rapamycin News
    @RapaNews (Twitter)

    RT @AgingJrnl: Watch an #agingshort #video about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correla…
    view full post

    October 7, 2024

    1

  • Aging-US
    @AgingJrnl (Twitter)

    Watch an #agingshort #video about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease." @VCU_Biology @unibirmingham https://t.co/oowkEBZpAC #aging #neurology #oa #publishing https://t.co/3892uEB3Tp
    view full post

    October 7, 2024

    3

    1

  • Aging-US
    @AgingJrnl (Twitter)

    #PaperoftheDay: "mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease" DOI ⬇️ https://t.co/oowkEBZpAC #ketamine #aging #rapamycin #research #openaccess #peerreviewed #publishing
    view full post

    August 9, 2024

  • Health365Info.com
    @health365Info (Twitter)

    https://t.co/PaKPsRLyNS A new research paper titled 'mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease" has been published in Aging.
    view full post

    August 7, 2024

  • Aging-US
    @AgingJrnl (Twitter)

    Listen to an #audio reading of the #pressrelease about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease." https://t.co/md3XFZV1ND #aging #soundcloud #podcast #press #openaccess
    view full post

    August 7, 2024

    1

  • Aging-US
    @AgingJrnl (Twitter)

    #TrendingWithImpact: A new #research paper was #published in Volume 16, Issue 14 on July 26, entitled, “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.” #Press: https://t.co/Cmzz63Odj9 #aging #oa
    view full post

    August 7, 2024

  • Aging-US
    @AgingJrnl (Twitter)

    Watch an #agingshort #video about this #research paper: "mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease." @VCU_Biology @unibirmingham https://t.co/oowkEBZpAC #aging #neurology #oa #publishing https://t.co/IDsVR4zZXK
    view full post

    August 7, 2024

  • Mind Your Science!
    @MindYourSci (Twitter)

    RT @agingdoc1: mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disea…
    view full post

    August 5, 2024

    2

  • NADIA EB
    @NADYEUGENY (Twitter)

    RT @agingdoc1: mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disea…
    view full post

    August 4, 2024

    2

  • Agingdoc
    @agingdoc1 (Twitter)

    mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease https://t.co/JfU6RdglEl https://t.co/k1JD2vCROz
    view full post

    August 4, 2024

    6

    2

  • Aging Papers
    @PapersAging (Twitter)

    mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease https://t.co/3PdGfCIeQs
    view full post

    August 3, 2024

  • VCU Life Sciences and Sustainability | Richmond VA

    ... 10.18632/aging.206033 #aging #neurology #rapamycin #mTORC1 #research #openaccess #peerreview #journal #publication #publishing #trending #meded #agingshort # ...
    view full post

    December 15, 2025

    Facebook

  • MTORC1 in Monocytes Tied to Size Variation, Mental Disorders ...

    ... 10.18632/aging.206033. Corresponding Author: Jon Berner. /Public Release. This material from the originating organization/author(s) might be ...
    view full post

    August 8, 2024

    News

Abstract Synopsis

  • The study explores how mTORC1 activity, indicated by phosphorylated p70S6K levels, is linked to physical traits like height and neuropsychiatric conditions such as anxiety and autism, as well as responses to drugs like ketamine and rapamycin.
  • Blood samples from 27 women were analyzed alongside clinical data, biometric measurements, and questionnaires to identify patterns in medication effectiveness and neuropsychiatric features.
  • Results showed that mTORC1 activity is a strong predictor of physical characteristics and treatment response, suggesting that a simple test could help personalize medication strategies and improve understanding of neuropsychiatric disorders.